Sluggish manufacturing figure for December poised to drag 2010 GDP down

Industrial production’s “disappointing” +9.0% yoy (-11.8% mom sa) reflects the ongoing volatility in the pharmaceuticals industry, according to OCBC.

The drug manufacturing sector slowed from +189% yoy in Nov to +3.3% yoy in December due to a
different mix of active pharmaceutical ingredients being produced.

OCBC said the industrial sector “disappointed” with their output.

Despite the 10.8% yoy (-+3.0% mom sa) growth posted by other manufacturing sectors, OCBC said theat the 2010 flash GDP growth estimates are still likely to be revised down from +12.5% yoy to 11.8% yoy, bringing the full-year growth to 14.5% yoy instead of 14.7% yoy.

For 2011, the bank expects manufacturing growth to moderate from 30% yoy to single-digit growth of 5.6% yoy.

GDP growth will also similarly ease from double-digit expansion to 4.5% yoy, OCBC said.

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia